Skip to main content
Log in

The effect of anabolic steroids on the gastrointestinal system, kidneys, and adrenal glands

  • Published:
Current Sports Medicine Reports

Abstract

Over the past several decades we have seen an increase in the prevalence of anabolic steroid use by athletes. Because use of anabolic steroids is illicit, much of our knowledge of their side effects is derived from case reports, retrospective studies, or comparisons with studies in other similar patient groups. It has been shown that high-dose anabolic steroids have an effect on lowering high-density lipoprotein, increasing low-density lipoprotein, and increasing the atherogenic-promoting apolipoprotein A. Steroid abuse can also be hepatotoxic, promoting disturbances such as biliary stasis, peliosis hepatis, and even hepatomas, which are all usually reversible upon discontinuation. Suppression of the hypothalamic adrenal axis can also lead to profound adrenal changes that are also reversible with time. Although rare, renal side effects have also been documented, leading to acute renal failure and even Wilms’ tumors in isolated cases. Much of our knowledge of these potentially severe but usually limited side effects is confounded by use of combinations of different steroid preparations and by the concomitant use with other substances. Physicians must target their efforts at counseling adolescents and other athletes about the potential harms of androgenic anabolic steroids and the legal options to improve strength and performance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Reents S: Androgenic-anabolic steroids. In Sport and Exercise Pharmacology. Champaign: Human Kinetics; 2000:161–181.Recent good review of the pharmacology of anabolic steroids and their biochemical properties. Looks at how chemical substances affect exercise performance in athletes.

    Google Scholar 

  2. Hickson RC, Ball KL, Falduto MT: Adverse effects of anabolic steroids. Med Toxicol Adverse Drug Exp 1989, 4:254–271.

    Article  CAS  PubMed  Google Scholar 

  3. Hall R: Abuse of supraphysiologic doses of anabolic steroids. South Med J 2005, 98:550–555.Most recent review article regarding specific side effects of high doses of AAS. Article reviews some of the history of AAS and the mechanisms for utilizing supraphysiologic doses of AAS. The article then reviews the major side effects broken down by organ system.

    Article  PubMed  Google Scholar 

  4. Shahidi NT: A review of the chemistry, biological action, and clinical applications of anabolic-androgenic steroids. Clin Ther 2001, 23:1355–1390.

    Article  CAS  PubMed  Google Scholar 

  5. National Institute on Drug Abuse Research Report - Steroid Abuse and Addiction. National Institutes of Health Publication No. 00-3721. Bethesda: National Institutes of Health; 2000.

    Google Scholar 

  6. Sturmi JE, Diorio DJ: Anabolic agents. Clin Sports Med 1998, 17:261–282.A comprehensive review of four different types of anabolic agents used by athletes. The article reviews physiology and chemistry as well as performance and medical side effects.

    Article  CAS  PubMed  Google Scholar 

  7. Haupt HA, Rovere GD: Anabolic steroids: a review of the literature. Am J Sports Med 1984, 12:469–484.

    Article  CAS  PubMed  Google Scholar 

  8. Snyder PJ: Androgens. In Goodman and Gilman’s The Pharmacological Basis of Therapeutics, edn 10. Edited by HardmanJG, LE, Limbird, Gilman AG. New York: McGraw Hill;2001:1635–1648.

    Google Scholar 

  9. Wu FCW: Endocrine aspects of anabolic steroids. Clin Chem 1997, 43:1289–1292.

    CAS  PubMed  Google Scholar 

  10. Hartgens F, Rietjens G, Keizer HA, et al.: Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a). Br J Sports Med 2004, 38:253–259.A recent study evaluating the effects of anabolic agents on apolipoproteins and overall lipid panel in strength athletes. The study is nonblinded, but looks at the relationship between changes in lipids profiles as they may be further indicators of cardiovascular risk. Focuses predominantly on HDL subfractions and apolipoprotein(a) and lipoprotein.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Hartgens F, Kuipers H: Effects of androgenic-anabolic steroids in athletes. Sports Med 2004, 34:513–554.

    Article  PubMed  Google Scholar 

  12. Lippi G, Guidi G, Ruzzenente O, et al.: Effects of nandrolone decanoate on serum Lp(a), lipids, and lipoproteins in women with postmenopausal osteoporosis. Scand J Clin Lab Invest 1997, 57:507–511.

    Article  CAS  PubMed  Google Scholar 

  13. Teruel JL, Lasuncion MA, Rivera M, et al.: Nandrolone decanoate reduces serum lipoprotein(a) concentrations in hemodialysis patients. Am J Kidney Dis 1997, 29:569–575.

    Article  CAS  PubMed  Google Scholar 

  14. Cicardi M, Bergamaschini L, Tucci A, et al.: Morphologic evaluation of the liver in hereditary angioedema patients on long-term treatment with androgen derivatives. J Allergy Clin Immunol 1983, 72:294–298.

    Article  CAS  PubMed  Google Scholar 

  15. Pecking A, Lejolly JM, Najean Y: Hepatic toxicity of androgen therapy in aplastic anemia. Nouv Rev Fr Hematol 1980, 22:257–265.

    CAS  PubMed  Google Scholar 

  16. Cohen JC, Noakes TD, Benade AJS: Hypercholesteremia in male power lifters using anabolic-androgenic steroids. Physician Sportsmed 1988, 16:49–56.

    Google Scholar 

  17. Bagheri SA, Bayer JL: Peliosis hepatis associated with androgenic-anabolic steroid therapy-a severe form of hepatic injury. Ann Intern Med 1974, 81:610–618.

    Article  CAS  PubMed  Google Scholar 

  18. Socas L, Zumbado M, Perez-Luzardo O, et al.: Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature. Br J Sports Med 2005, 39:e27.A case report of two male body builders using high doses of AAS who developed serious liver disease, including adenocarcinomas. One patient was asymptomatic; the other was hospitalized for acute renal failure as well. The cases follow the patients and shows the long-term reversibility of the disease and the need for monitoring of patients taking AAS.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  19. Peters RL: Pathology of hepatocellular carcinoma. In Hepatocellular Carcinoma. Edited by Okuda K, Peters RL.New York: John Wiley & Sons; 1976:107–168.

    Google Scholar 

  20. Friedl KE: Effects of anabolic steroids on physical health. In Anabolic Steroids in Sport and Exercise. Edited by YesalisCE. Champaign: Human Kinetics; 1993:107–150.

    Google Scholar 

  21. Vihko R: Endocrine consequences of androgenic-anabolic steroids in male athletes. In Official Proceedings from International Athletic Foundation World Symposium on Doping in Sport. Edited by Bellotti P, Benzi G, Ljungqvist A. Florence,Italy. 1987:141–147.

    Google Scholar 

  22. Juhn M: Popular sports supplements and ergogenic aids. Sports Med 2003, 33:921–939.

    Article  PubMed  Google Scholar 

  23. Maravelias C, Dona A, Stefanidou M, Spiliopoulou C: Adverse effects of anabolic steroids in athletes: a constant threat. Toxicol Lett 2005, 158:167–175.

    Article  CAS  PubMed  Google Scholar 

  24. VanHelder WP, Kofman E, Tremblay MS: Anabolic steroids in sport. Can J Sports Sci 1992, 16:248–257.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Karl B. Fields MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Modlinski, R., Fields, K.B. The effect of anabolic steroids on the gastrointestinal system, kidneys, and adrenal glands. Curr Sports Med Rep 5, 104–109 (2006). https://doi.org/10.1007/s11932-006-0039-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11932-006-0039-7

Keywords

Navigation